The Myogenesis Program Drives Clonal Selection and Drug Resistance in Rhabdomyosarcoma

Added 46 days ago (17.06.2021)
Authors: Patel, A. G., Chen, X., Huang, X., Clay, M. R., Komarova, N., Krasin, M. J., Pappo, A., Tillman, H., Orr, B. A., McEvoy, J., Gordon, B., Blankenship, K., Reilly, C., Zhou, X., Norrie, J. L., Karlstrom, A., Yu, J., Wodarz, D., Stewart, E., Dyer, M. A.
Source: bioRxiv
Read article